Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPF induction chemotherapy for locally advanced oral squamous cell carcinoma
ChiCTR1800016896Phase 3Recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Feb 2017
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of docetaxel, cisplatin and fluorouracil in Oral Mucosal Carcinoma (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Overall survival. Started Feb 2017; status: recruiting.
02
Drugs
docetaxelcisplatinfluorouracil
03
Conditions
Oral Mucosal Carcinoma
Beyond the preview
Go deeper on ChiCTR1800016896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016896.